Bruce Altevogt is a Director of Science Policy and Science Advocacy at Pfizer Inc.’s Policy Center of Excellence, within Global Policy and International Public Affairs. In this role Dr. Altevogt is responsible for policy issues in support of Pfizer’s research & development enterprise as well as developing and implementing a science advocacy platform.
Prior to joining Pfizer Inc., Dr. Altevogt spent over 11 years as a senior program officer on the Board on Health Sciences Policy at the Institute of Medicine (IOM). While at the IOM, he worked on policy issues related to basic and translational research, drug discovery and development, and preparedness for catastrophic events. He oversaw the publication of over 50 IOM reports and directed multiple IOM studies. In his capacity at the IOM he served as director of the Forum on Medical and Public Health Preparedness for Catastrophic Events and the Forum on Neuroscience and Nervous System Disorders Forum.
Dr. Altevogt received his doctorate from Harvard University’s Program in Neuroscience. Following more than 10 years of research, Dr. Altevogt joined The National Academies as a science and technology policy fellow with the Christine Mirzayan Science & Technology Policy Graduate Fellowship Program. He received his B.A. from the University of Virginia in Charlottesville, where he majored in Biology and minored in South Asian Studies. He is a published author of multiple scientific articles.
BlogPuerto Rico’s Recovery: Five Things You Need to Know
- February 21, 2018
In The NewsWhy so many medicines are in short supply months after Hurricane Maria
- February12, 2018
In The NewsNew Emergency Rule: Challenge for Some, Good for All
- February 7, 2018
In The NewsPharma Supply Chain, Industry Still Recovering from Hurricane Maria
- January 29, 2018